|
FY2025
12 months to Dec 31, 2025
|
FY2024
7 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Change in fair value of overallotment liability | ||
| Interest earned on investments held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Reimbursement receivable | ||
| Accrued offering costs | ||
| Accounts payable and accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Placements Warrants | ||
| Proceeds from promissory note - related party | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash - Beginning | ||
| Cash - Ending | ||
| Non-Cash Investing and Financing Activities: | ||
| Remeasurement of Class A ordinary shares to redemption amount |
Loading...
